 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || TORL-2-307-MAB / TORL Biotherap
Enrollment closed, Metastases: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer (clinicaltrials.gov) - Aug 9, 2024
P1, N=70, Active, not recruiting, Sponsor: TORL Biotherapeutics, LLC
Recruiting --> Active, not recruiting
- ||| TORL-2-307-MAB / TORL Biotherap
Enrollment open, Metastases: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer (clinicaltrials.gov) - Feb 7, 2022
P1, N=70, Recruiting, Sponsor: TORL Biotherapeutics, LLC
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| TORL-2-307-MAB / TORL Biotherap
New P1 trial, Metastases: First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer (clinicaltrials.gov) - Dec 15, 2021
P1, N=70, Not yet recruiting, Sponsor: TORL Biotherapeutics, LLC